Cited by 1,521Cancer-related Molecular PathwaysHeat shock proteins researchPI3K/AKT/mTOR signaling in cancer

The DOI matches its Crossref record; 65 of the 72 references it cites were found in a registry or an index.

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53

Open access

Pomerantz, Jason, Schreiber-Agus, Nicole, Liégeois, Nanette J, Silverman, Adam, Alland, Leila, Chin, Lynda, Potes, Jason, Chen, Ken, Orlow, Irene, Lee, Han-Woong, Cordon-Cardo, Carlos, DePinho, Ronald A·1998·Cell

DOI 10.1016/s0092-8674(00)81400-2

Open this paper in CoChat — free account Open PDF

Abstract

The INK4a gene encodes two distinct growth inhibitors--the cyclin-dependent kinase inhibitor p16Ink4a, which is a component of the Rb pathway, and the tumor suppressor p19Arf, which has been functionally linked to p53. Here we show that p19Arf potently suppresses oncogenic transformation in primary cells and that this function is abrogated when p53 is neutralized by viral oncoproteins and dominant-negative mutants but not by the p53 antagonist MDM2. This finding, coupled with the observations that p19Arf and MDM2 physically interact and that p19Rrf blocks MDM2-induced p53 degradation and transactivational silencing, suggests that p19Arf functions mechanistically to prevent MDM2's neutralization of p53. Together, our findings ascribe INK4a's potent tumor suppressor activity to the cooperative actions of its two protein products and their relation to the two central growth control pathways, Rb and p53.

Integrity signals

Registry

Crossref · 10.1016/s0092-8674(00)81400-2

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells
Gorman, C., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,674
Cancer Cell Cycles
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
The p53 tumour suppressor gene
Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312

Show all 72 references

Research works printed but not linked: 6

Brenner, 1996, Preferential loss of expression of p16INK4a rather than p19ARF in breast cancer, Clin. Cancer Res., 2, 1993
Elledge, 1996, A question of balance, Trends Biochem. Sci., 6, 388
Kinoshita, 1996, Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer, Cancer Res., 56, 5557
Quelle, 1995, Cloning and characterization of murine p16INK4a and p15INK4b genes, Oncogene, 11, 635
Schreiber-Agus, 1994, Evolutionary relationships and functional conservation among vertebrate Max-associated proteins, Oncogene, 9, 3167
Schreiber-Agus, 1997, An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3, Cell, 80, 777, 10.1016/0092-8674(95)90356-9 · DOI

Sorted by citations

Items 401–500 of 1,001

Aberrant DNA methylation in malignant melanoma
Schinke, C., Mo, Y., Yu, Y., Amiri, K., Sosman, J. A., Greally, J. M., & Verma, A. K. (2010) · Melanoma Research · doi:10.1097/cmr.0b013e328338a35a · Cited by 100
Are microRNAs true sensors of ageing and cellular senescence?
Williams, J. P., Smith, F., Kumar, S., Vijayan, M., & Reddy, P. H. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.11.008 · Cited by 105
Disruption of p16 and Activation of Kras in Pancreas Increase Ductal Adenocarcinoma Formation and Metastasis in vivo
Qiu, W., Sahin, F., Iacobuzio-Donahue, C. A., Garcia-Carracedo, D., Wang, W. M., Kuo, C.-Y., Chen, D., Arking, D. E., Lowy, A. M., Hruban, R. H., et al. (2011) · Oncotarget · doi:10.18632/oncotarget.357 · Cited by 99
The roles and regulation of TBX3 in development and disease
Khan, S. F., Damerell, V., Omar, R., Du Toit, M., Khan, M., Maranyane, H. M., Mlaza, M., Bleloch, J., Bellis, C., Sahm, B. D. B., et al. (2020) · Gene · doi:10.1016/j.gene.2019.144223 · Cited by 99
“…M anuscript A uthor M anuscript A uthor M anuscript senescence and apoptosis (Berkovich et al., 2003; Brugarolas et al., 1995; Inoue et al., 1999; Pomerantz et al., 1998). p16INK4a, like other members of the Ink4 family, functions by blocking the kinase active sites of cyclin-dependent kinases…”
Background
Polyploid cells rewire DNA damage response networks to overcome replication stress-induced barriers for tumour progression
Zheng, L., Dai, H., Zhou, M., Li, X., Liu, C., Guo, Z., Wu, X., Wu, J., Wang, C., Zhong, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms1825 · Cited by 105
Cancer stem-like cells of glioblastoma characteristically express MMP-13 and display highly invasive activity
Takahashi, Y. (2010) · International Journal of Oncology · doi:10.3892/ijo_00000764 · Cited by 101
MDM2 Enhances the Function of Estrogen Receptor α in Human Breast Cancer Cells
Saji, S., Okumura, N., Eguchi, H., Nakashima, S., Suzuki, A., Toi, M., Nozawa, Y., Saji, S., & Hayashi, S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4339 · Cited by 99
Distinct Gene Expression Profiling after Infection of Immature Human Monocyte-Derived Dendritic Cells by the Attenuated Poxvirus Vectors MVA and NYVAC
Guerra, S., Nájera, J. L., González, J. M., López-Fernández, L. A., Climent, N., Gatell, J. M., Gallart, T., & Estéban, M. (2007) · Journal of Virology · doi:10.1128/jvi.00444-07 · Cited by 98
p14 methylation in human colon cancer is associated with microsatellite instability and wild-type p53
Shen, L., Kondo, Y., Hamilton, S. R., Rashid, A., & Issa, J. J. (2003) · Gastroenterology · doi:10.1053/gast.2003.50102 · Cited by 98
Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells.
Satyamoorthy, K., Chehab, N. H., Waterman, M. J. F., Lien, M. C., El‐Deiry, W. S., Herlyn, M., & Halazonetis, T. D. (2000) · PubMed · Cited by 98
p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53
Lindström, M. S., Klangby, U., & Wiman, K. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204303 · Cited by 101
Whole‐genome methylation analysis of benign and malignant colorectal tumours
Beggs, A. D., Jones, A., El‐Bahwary, M., Abulafi, M., Hodgson, S. V., & Tomlinson, I. P. M. (2012) · The Journal of Pathology · doi:10.1002/path.4132 · Cited by 97
FoxM1c Counteracts Oxidative Stress-induced Senescence and Stimulates Bmi-1 Expression
Li, S. K. M., Smith, D. K., Leung, W. Y., Cheung, A. M. S., Lam, E. W. ‐., Dimri, G. P., & Yao, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709604200 · Cited by 99
MDM2’s social network
Fåhræus, R., & Olivares‐Illana, V. (2013) · Oncogene · doi:10.1038/onc.2013.410 · Cited by 103
p53 in neurodegenerative diseases and brain cancers
Checler, F., & da Costa, C. A. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.009 · Cited by 99
An Alternative Splice Form of Mdm2 Induces p53-independent Cell Growth and Tumorigenesis
Steinman, H. A., Burstein, E., Lengner, C., Gosselin, J., Pihan, G., Duckett, C. S., & Jones, S. N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305966200 · Cited by 96
Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma
Mai, W. X., Gosa, L., Daniëls, V. W., Ta, L. H., Tsang, J., Higgins, B., Gilmore, W. B., Bayley, N. A., Harati, M. D., Lee, J. T., et al. (2017) · Nature Medicine · doi:10.1038/nm.4418 · Cited by 97
Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia
Saddler, C. M., Ouillette, P. D., Kujawski, L. A., Shangary, S. K., Talpaz, M., Kaminski, M. S., Erba, H. P., Shedden, K., Wang, S., & Malek, S. N. (2007) · Blood · doi:10.1182/blood-2007-09-112698 · Cited by 96
Cell cycle regulatory functions of the human oncoprotein MDM2.
Deb, S. P. (2003) · PubMed · Cited by 96
The role of p53 in pigmentation, tanning and melanoma
Box, N. F., & Terzian, T. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00495.x · Cited by 95
Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt–Mdm2–p53 pathway
Rogulski, K. R., Li, Y., Rothermund, K. D., Pu, L., Watkins, S. C., Yi, F., & Prochownik, E. V. (2005) · Oncogene · doi:10.1038/sj.onc.1208897 · Cited by 96
Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization
Rizos, H., Darmanian, A., Mann, G. J., & Kefford, R. F. (2000) · Oncogene · doi:10.1038/sj.onc.1203629 · Cited by 95
Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma
Møller, M. B., Ino, Y., Gerdes, A., Skøjdt, K., Louis, D., & Pedersen, N. (1999) · Leukemia · doi:10.1038/sj.leu.2401315 · Cited by 95
P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2
Xirodimas, D. P., Chisholm, J., Desterro, J. M. S., Lane, D. P., & Hay, R. T. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03310-0 · Cited by 94
Long Noncoding RNA ANRIL Regulates Proliferation of Non-small Cell Lung Cancer and Cervical Cancer Cells.
Naemura, M., Murasaki, C., Inoue, Y., Okamoto, H., & Kotake, Y. (2015) · PubMed · Cited by 94
Protein serine/threonine phosphatase-1 dephosphorylates p53 at Ser-15 and Ser-37 to modulate its transcriptional and apoptotic activities
Li, D. W.-C., Liu, J.-P., Schmid, P. C., Schlosser, R., Feng, H., Liu, W.-B., Yan, Q., Gong, L., Sun, S.-M., Deng, M., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209334 · Cited by 98
Heterogeneous Methylation and Deletion Patterns of the INK4a/ARF Locus Within Prostate Carcinomas
Konishi, N., Nakamura, M., Kishi, M., Nishimine, M., Ishida, E., & Shimada, K. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62547-3 · Cited by 93
A Novel Cellular Protein (MTBP) Binds to MDM2 and Induces a G1 Arrest That Is Suppressed by MDM2
Boyd, M. T., Vlatković, N., & Haines, D. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004252200 · Cited by 93
p16INK4a Promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma
Taniai, M., Higuchi, H., Burgart, L. J., & Gores, G. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36021 · Cited by 93
mdm2: a bridge over the two tumour suppressors, p53 and Rb
Yap, D., Hsieh, J.-K., Chan, F., & Lü, X. (1999) · Oncogene · doi:10.1038/sj.onc.1202954 · Cited by 93
Nucleolar Proteins Suppress Caenorhabditis elegans Innate Immunity by Inhibiting p53/CEP-1
Fuhrman, L. E., Goel, A., Smith, J. P., Shianna, K. V., & Aballay, A. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000657 · Cited by 92
Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization
Saxena, A. D., Rorie, C. J., Dimitrova, D. D., Daniely, Y., & Borowiec, J. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209714 · Cited by 94
Oncogenic Ras Induces p19ARF and Growth Arrest in Mouse Embryo Fibroblasts Lacking p21Cip1 and p27Kip1 without Activating Cyclin D-dependent Kinases
Groth, A., Weber, J. D., Willumsen, B. M., Sherr, C. J., & Roussel, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003417200 · Cited by 92
Influence of p53 mutations on prognosis of patients with glioblastoma
Shiraishi, S., Tada, K., Nakamura, H., Makino, K., Kochi, M., Saya, H., Kuratsu, J., & Ushio, Y. (2002) · Cancer · doi:10.1002/cncr.10677 · Cited by 91
p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer
Kawamoto, K., Enokida, H., Gotanda, T., Kubo, H., Nishiyama, K., Kawahara, M., & Nakagawa, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.072 · Cited by 91
Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines
Sartor, M., Steingrimsdottir, H., Elamin, F., Gäken, J. A., Warnakulasuriya, S., Partridge, M., Thakker, N., Johnson, N. W., & Tavassoli, M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690505 · Cited by 91
Contribution of two independent MDM2-binding domains in p14ARF to p53 stabilization
Lohrum, M. A. E., Ashcroft, M. A., Kubbutat, M. H. G., & Vousden, K. H. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00472-3 · Cited by 91
Cell Transformation by the E7 Oncoprotein of Human Papillomavirus Type 16: Interactions with Nuclear and Cytoplasmic Target Proteins
Zwerschke, W., & Jansen‐Dürr, P. (1999) · Advances in cancer research · doi:10.1016/s0065-230x(08)61022-2 · Cited by 92
Nuclear exclusion of p53 in a subset of tumors requires MDM2 function
Lu, W., Pochampally, R. R., Chen, L., Chomnawang, M. T., Wang, Y., & Chen, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203262 · Cited by 90
Update on familial cancer syndromes and the skin
Tsao, H. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.104681 · Cited by 90
E2F4 and E2F1 Have Similar Proliferative Properties but Different Apoptotic and Oncogenic Properties In Vivo
Wang, D., Russell, J., & Johnson, D. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.10.3417-3424.2000 · Cited by 90
The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
Argentini, M., Barboule, N., & Wasylyk, B. (2001) · Oncogene · doi:10.1038/sj.onc.1204241 · Cited by 90
Regulation and activation of p53 and its family members
Lohrum, M. A. E., & Vousden, K. H. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400625 · Cited by 91
Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma
Hedberg, M. L., Berry, C. T., Moshiri, A. S., Xiang, Y., Yeh, C. J., Atillasoy, C., Capell, B. C., & Seykora, J. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073478 · Cited by 94
The Involvement of MAPK Signaling Pathways in Determining the Cellular Response to p53 Activation
Brown, L. M., & Benchimol, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507951200 · Cited by 91
p16INK4a is a Prognostic Marker in Resected Ductal Pancreatic Cancer
Gerdes, B., Ramaswamy, A., Ziegler, A., Lang, S. A., Kersting, M., Baumann, R., Wild, A., Moll, R., Rothmund, Μ., & Bartsch, D. K. (2002) · Annals of Surgery · doi:10.1097/00000658-200201000-00007 · Cited by 89
Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines
Park, Y.-B., Park, M. J., Kimura, K., Shimizu, K., Lee, S. H., & Yokota, J. (2002) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(01)00575-1 · Cited by 90
Human ARF protein interacts with Topoisomerase I and stimulates its activity
Karayan, L., Riou, J., Seité, P., Migeon, J., Cantereau, A., & Larsen, C. (2001) · Oncogene · doi:10.1038/sj.onc.1204170 · Cited by 89
A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection.
Zhu, J. W., DeRyckere, D., Li, F. X., Wan, Y. Y., & DeGregori, J. V. (1999) · PubMed · Cited by 89
Activation of an Endogenous Suicide Response after Perturbation of rRNA Synthesis Leads to Neurodegeneration in Mice
Parlato, R., Kreiner, G., Erdmann, G., Rieker, C., Stotz, S., Savenkova, E., Berger, S., Grummt, I., & Schütz, G. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2439-08.2008 · Cited by 88
Novel targets of Akt, p21, and MDM2
Zhou, B. P., & Hung, M. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70128-0 · Cited by 88
Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.
Nakamura, M., Sakaki, T., Hashimoto, H., Nakase, H., Ishida, E., Shimada, K., & Konishi, N. (2001) · PubMed · Cited by 88
Interplay between dietary inducers of GST and theGSTM-1 genotype in colon cancer
Slattery, M. L., Kampman, E., Samowitz, W. S., Caan, B. J., & Potter, J. D. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000901)87:5 · Cited by 2
Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age
Movsas, B., Chapman, J. D., Greenberg, R. E., Hanlon, A. L., Horwitz, E. M., Pinover, W. H., Stobbe, C. C., & Hanks, G. E. (2000) · Cancer · doi:10.1002/1097-0142(20001101)89:9 · Cited by 149
A New Twist in the Feedback Loop: Stress-Activated MDM2 Destabilization is Required for p53 Activation
Stommel, J. M., & Wahl, G. M. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1522 · Cited by 90
The p53 Tumor Suppressor Protein Does Not Regulate Expression of Its Own Inhibitor, MDM2, Except under Conditions of Stress
Mendrysa, S. M., & Perry, M. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.2023-2030.2000 · Cited by 87
Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer
Jarmalaitė, S., Kannio, A., Anttila, S. L., Lazutka, J. R., & Husgafvel‐Pursiainen, K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11322 · Cited by 87
MicroRNAs, Aging, Cellular Senescence, and Alzheimer's Disease
Reddy, P. H., Williams, J. M., Smith, F., Bhatti, J. S., Kumar, S., Vijayan, M., Kandimalla, R. J. L., Kuruva, C. S., Wang, R., Mańczak, M., et al. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.009 · Cited by 89
From p63 to p53 across p73
Strano, S., Rossi, M., Fontemaggi, G., Munarriz, E. R., Soddu, S., Sacchi, A., & Blandino, G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02119-6 · Cited by 87
Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressorPreprint
Stegh, A. H., Brennan, C., Mahoney, J. E., Forloney, K. L., Jenq, H. T., Luciano, J. P., Protopopov, A. I., Chin, L., & DePinho, R. A. (2010) · Genes & Development · doi:10.1101/gad.1924710 · Cited by 88
Self-citation
The genetics of melanoma: recent advances
Hill, V. K., Gartner, J. J., Samuels, Y., & Goldstein, A. M. (2013) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153429 · Cited by 86
Replicative senescence revisited.
Marcotte, R., & Wang, E. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.7.b257 · Cited by 86
The transcription factor BACH1 at the crossroads of cancer biology: From epithelial–mesenchymal transition to ferroptosis
Igarashi, K., Nishizawa, H., Saiki, Y., & Matsumoto, M. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101032 · Cited by 89
Lentivector-Mediated Transfer of Bmi-1 and Telomerase in Muscle Satellite Cells Yields a Duchenne Myoblast Cell Line with Long-Term Genotypic and Phenotypic Stability
Cudré-Mauroux, C., Occhiodoro, T., König, S., Salmon, P., Bernheim, L., & Trono, D. (2003) · Human Gene Therapy · doi:10.1089/104303403322495034 · Cited by 86
Inhibition of nucleolar transcription as a trigger for neuronal apoptosis
Kalita, K. B., Makonchuk, D. Y., Gomes, C., Zheng, J., & Hetman, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05316.x · Cited by 88
Tbx3, the ulnar‐mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53‐independent pathway
Jerome‐Majewska, L. A., Jenkins, G. P., Ernstoff, E., Zindy, F., Sherr, C. J., & Papaioannou, V. E. (2005) · Developmental Dynamics · doi:10.1002/dvdy.20575 · Cited by 86
Genomic Analyses of Musashi1 Downstream Targets Show a Strong Association with Cancer-related Processes
Abreu, R. D. S., Sánchez-Díaz, P. C., Vogel, C., Burns, S. C., Ko, D., Burton, T. L., Vo, D. T., Chennasamudaram, S., Le, S., Shapiro, B. A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809605200 · Cited by 87
Pharmacological blockade of a β2AR-β-arrestin-1 signaling cascade prevents the accumulation of DNA damage in a behavioral stress model
Hara, M. R., Sachs, B. D., Caron, M. G., & Lefkowitz, R. J. (2013) · Cell Cycle · doi:10.4161/cc.23368 · Cited by 87
Prognostic Role ofE2F1and Members of theCDKN2ANetwork in Gastrointestinal Stromal Tumors
Haller, F., Gunawan, B., von Heydebreck, A., Schwager, S., Schulten, H.-J., Wolf-Salgó, J., Langer, C., Ramadori, G. P., Sültmann, H., & FÜZESI, L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0329 · Cited by 85
p19ARF Is Dispensable for Oncogenic Stress-Induced p53-Mediated Apoptosis and Tumor Suppression In Vivo
Tolbert, D., Lu, X., Yin, C., Tantama, M., & Dyke, T. V. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.370-377.2002 · Cited by 85
Versatile functions of p53 protein in multicellular organisms
Chumakov, P. M. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907130019 · Cited by 85
Hepatitis B Virus X Protein via the p38MAPK Pathway Induces E2F1 Release and ATR Kinase Activation Mediating p53 Apoptosis
Wang, W., Hullinger, R. L., & ANDRISANI, O. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801934200 · Cited by 87
Cyclin G1 associates with MDM2 and regulates accumulation and degradation of p53 protein
Kimura, S. H., & Nojima, H. (2002) · Genes to Cells · doi:10.1046/j.1365-2443.2002.00564.x · Cited by 85
Does the Antitumor Adenovirus ONYX-015/dl1520 Selectively Target Cells Defective in the p53 Pathway?
Dix, B. R., Edwards, S. J., & Braithwaite, A. W. (2001) · Journal of Virology · doi:10.1128/jvi.75.12.5443-5447.2001 · Cited by 84
Role of the newer p53 family proteins in malignancy
Irwin, M. S., & Kaelin, W. G. (2001) · APOPTOSIS · doi:10.1023/a:1009663809458 · Cited by 84
Genomic instability, mutations and expression analysis of the tumour suppressor genes p14ARF, p15INK4b, p16INK4a and p53 in actinic keratosis
Kanellou, P., Zaravinos, A., Zioga, M., Stratigos, A., Baritaki, S., Soufla, G., Zoras, O., & Spandidos, D. A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.01.042 · Cited by 83
REGγ modulates p53 activity by regulating its cellular localization
Liu, J., Yu, G., Zhao, Y., Zhao, D., Wang, Y., Wang, L., Liu, J., Li, L., Zeng, Y., Dang, Y., et al. (2010) · Journal of Cell Science · doi:10.1242/jcs.067405 · Cited by 83
Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF
Ko, A., Han, S. Y., Choi, C. H., Cho, H., Lee, M.-S., Kim, S., Song, J. S., Hong, K., Lee, H., Hewitt, S. M., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0072-0 · Cited by 85
Self-citation
Efficiency Alleles of the Pctr1 Modifier Locus for Plasmacytoma Susceptibility
Zhang, S.-L., Dubois, W., Ramsay, E. S., Bliskovski, V., Morse, H. C., Taddesse-Heath, L., Vass, W. C., DePinho, R. A., & Mock, B. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.1.310-318.2001 · Cited by 83
Self-citation
Targeted Therapies for Pancreatic Cancer
Amanam, I. U., & Chung, V. M. (2018) · Cancers · doi:10.3390/cancers10020036 · Cited by 85
Deregulation and Targeting of TP53 Pathway in Multiple Myeloma
Jovanović, K., Escure, G., Demonchy, J., Willaume, A., de Wyngaert, Z. V., Farhat, M.-M., Chauvet, P., Facon, T. T. F., Quesnel, B., & Manier, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00665 · Cited by 86
p19 Arf Suppresses Growth, Progression, and Metastasis of Hras-Driven Carcinomas through p53-Dependent and -Independent Pathways
Kelly‐Spratt, K. S., Gurley, K. E., Yasui, Y., & Kemp, C. J. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020242 · Cited by 84
Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas
Yoshino, A., Katayama, Y., Ogino, A., Watanabe, T., Yachi, K., Ohta, T., Komine, C., Yokoyama, T., & Fukushima, T. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9316-9 · Cited by 82
Cellular Senescence and Vascular Disease: Novel Routes to Better Understanding and Therapy
Yin, H., & Pickering, J. G. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.051 · Cited by 82
The molecular pathogenesis of acute myeloid leukemia
Steffen, B., Müller‐Tidow, C., Schwäble, J., Berdel, W. E., & Serve, H. L. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.10.012 · Cited by 85
ANRIL Promoter DNA Methylation: A Perinatal Marker for Later Adiposity
Lillycrop, K. A., Murray, R. J. S., Cheong, C. Y., Teh, A. L., Clarke-Harris, R., Barton, S. J., Costello, P. M., Garratt, E. S., Cook, E., Titcombe, P., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.03.037 · Cited by 85
The E2F family and the role of E2F1 in apoptosis
Wu, Z., Zheng, S., & Yu, Q. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.06.004 · Cited by 86
PI3Kinase signaling in glioblastoma
Lino, M. M., & Merlo, A. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0442-z · Cited by 83
p19Arf Inhibits the Invasion of Hepatocellular Carcinoma Cells by Binding to C-terminal Binding Protein
Chen, Y., Paliwal, S., Draheim, K., Grossman, S. R., & Lewis, B. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1960 · Cited by 80
E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells.
Elliott, M. J., Dong, Y., Yang, H., & McMasters, K. M. (2001) · PubMed · Cited by 80
The cell cycle and development: redundant roles of cell cycle regulators
Zhang, P. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00032-0 · Cited by 80
Cyclin-dependent kinase inhibitors: novel anticancer agents
Mani, S., Wang, C., Wu, K., Francis, R., & Pestell, R. G. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.8.1849 · Cited by 80
Oncogenic Ras-mediated Cell Growth Arrest and Apoptosis are Associated with Increased Ubiquitin-dependent Cyclin D1 Degradation
Shao, J., Sheng, H., DuBois, R. N., & Beauchamp, R. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002235200 · Cited by 81
Regulation of Pluripotency and Self- Renewal of ESCs through Epigenetic- Threshold Modulation and mRNA Pruning
Jia, J., Zheng, X., Hu, G., Cui, K., Zhang, J., Zhang, A., Jiang, H., Lu, B., Yates, J. R., Liu, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.09.023 · Cited by 84
Smad Ubiquitylation Regulatory Factor 1/2 (Smurf1/2) Promotes p53 Degradation by Stabilizing the E3 Ligase MDM2
Nie, J., Xie, P., Liu, L., Xing, G., Chang, Z., Yin, Y., Tian, C., He, F., & Zhang, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.126920 · Cited by 79
Oncogene-Induced Senescence Does Not Require the p16INK4a or p14ARF Melanoma Tumor Suppressors
Haferkamp, S., Scurr, L. L., Becker, T. M., Frausto, M., Kefford, R. F., & Rizos, H. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.5 · Cited by 81
p53-Induced Apoptosis as a Safeguard against Cancer
Asker, C., Wiman, K. G., & Selivanova, G. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1446 · Cited by 79
Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphoma
Grønbæk, K., Brown, P. D. N., Møller, M. B., Nedergaard, T., Ralfkiaer, E. M., Mӧller, P., Zeuthen, J., & Guldberg, P. (2000) · Leukemia · doi:10.1038/sj.leu.2401901 · Cited by 79
The Role of p53 in Suppression of KSHV Cyclin-induced Lymphomagenesis
Verschuren, E. W., Hodgson, J., Gray, J. W., Kogan, S. C., Jones, N., & Evan, G. I. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1863 · Cited by 80
Genetic and Molecular Markers of Urothelial Premalignancy and Malignancy
Cordon‐Cardo, C., Côté, R. J., & Sauter, G. (2000) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/003655900750169338 · Cited by 78
Self-citation

Authors: Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., Cordon-Cardo, C., & DePinho, R. A.
Affiliations: Albert Einstein College of Medicine (US)
Memorial Sloan Kettering Cancer Center (US)
Corresponding author: DePinho, Ronald A
ORCID: Pomerantz, Jason
Liégeois, Nanette J
Chen, Ken
Orlow, Irene
Lee, Han-Woong
DePinho, Ronald A
Venue: Cell
Publisher: Elsevier BV
Published: 1998-03
Volume: 92
Issue: 6
Pages: 713-723
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/s0092-8674(00)81400-2
OpenAlex: W2039463309
Cited by: 1,521
References: 72
Citations by year: 2026: 4 · 2025: 10 · 2024: 6 · 2023: 23 · 2022: 19 · 2021: 23 · 2020: 19 · 2019: 16 · 2018: 12 · 2017: 24 · 2016: 27 · 2015: 32 · 2014: 44 · 2013: 44 · 2012: 47
FWCI: 64.86
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 5617 d)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (CA 47179, CA 47538, CADK97650, P01CA047179)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords: p19ARF, INK4A, MDM2, p53, tumor suppression, protein-protein interaction, p53 degradation, p53 transactivation, oncogenic transformation, Rb pathway, viral oncoproteins, dominant-negative mutant
MeSH terms: Animals, Biotin, Cell Line, Deoxyuracil Nucleotides, Lens, Crystalline, Neoplasm Proteins, Nuclear Proteins, Osteoblasts, Proteins, Proto-Oncogene Proteins, Staining and Labeling, Transformation, Genetic, Tumor Suppressor Protein p53, Retinoblastoma Protein, Apoptosis, Genes, p16, Tumor Suppressor Protein p14ARF, Mice, Proto-Oncogene Proteins c-mdm2, DNA Fragmentation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks